The effect of pioglitazone on reducing opioid and heroin dependence.

Not Applicable

Recruiting

• Conditions: Opiate and heroin-dependent patients.; Opioid abuse; F11.1

• Registration Number: IRCT20190427043389N2
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Opium and heroin-dependent patients admitted to Shahid Beheshti Hospital in Zanjan are included in the study.
Opium and heroin-dependent patients referred to the clinic of beheshti training center of zanjan in the study.
The age range of patients is between 20 to 50 years.

Exclusion Criteria

chronic medical conditions include diabetes , severe liver disorder & severe heart disorder.
pioglitazone contraindications if any.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of the effect of pioglitazone on treatment outcome in opium and heroin dependent patients. Timepoint: three months. Method of measurement: Based on the nottingham questionnaire.

Secondary Outcome Measures

Name	Time	Method
Determination of quality of life in pioglitazone recipient group. Timepoint: three months. Method of measurement: Based on the nottingham questionnaire.